BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Campione E, Lanna C, Cosio T, Rosa L, Conte MP, Iacovelli F, Romeo A, Falconi M, Del Vecchio C, Franchin E, Lia MS, Minieri M, Chiaramonte C, Ciotti M, Nuccetelli M, Terrinoni A, Iannuzzi I, Coppeta L, Magrini A, Bernardini S, Sabatini S, Rosapepe F, Bartoletti PL, Moricca N, Di Lorenzo A, Andreoni M, Sarmati L, Miani A, Piscitelli P, Squillaci E, Valenti P, Bianchi L. Lactoferrin as Antiviral Treatment in COVID-19 Management: Preliminary Evidence. Int J Environ Res Public Health 2021;18:10985. [PMID: 34682731 DOI: 10.3390/ijerph182010985] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 17.0] [Reference Citation Analysis]
Number Citing Articles
1 Bolat E, Eker F, Kaplan M, Duman H, Arslan A, Saritaş S, Şahutoğlu AS, Karav S. Lactoferrin for COVID-19 prevention, treatment, and recovery. Front Nutr 2022;9. [DOI: 10.3389/fnut.2022.992733] [Reference Citation Analysis]
2 Cutone A, Rosa L, Bonaccorsi di Patti MC, Iacovelli F, Conte MP, Ianiro G, Romeo A, Campione E, Bianchi L, Valenti P, Falconi M, Musci G. Lactoferrin Binding to SARS-CoV-2 Spike Glycoprotein Blocks Pseudoviral Entry and Relieves Iron Protein Dysregulation in Several In Vitro Models. Pharmaceutics 2022;14:2111. [PMID: 36297546 DOI: 10.3390/pharmaceutics14102111] [Reference Citation Analysis]
3 Morello R, De Rose C, Cardinali S, Valentini P, Buonsenso D. Lactoferrin as Possible Treatment for Chronic Gastrointestinal Symptoms in Children with Long COVID: Case Series and Literature Review. Children 2022;9:1446. [DOI: 10.3390/children9101446] [Reference Citation Analysis]
4 Esteves E, Mendes VM, Manadas B, Lopes R, Bernardino L, Correia MJ, Barros M, Esteves AC, Rosa N. COVID-19 Salivary Protein Profile: Unravelling Molecular Aspects of SARS-CoV-2 Infection. JCM 2022;11:5571. [DOI: 10.3390/jcm11195571] [Reference Citation Analysis]
5 Mohamed Y, El-maradny YA, Saleh AK, Nayl AA, El-gendi H, El-fakharany EM. A comprehensive insight into current control of COVID-19: Immunogenicity, vaccination, and treatment. Biomedicine & Pharmacotherapy 2022;153:113499. [DOI: 10.1016/j.biopha.2022.113499] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Kell DB, Pretorius E. The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications. Biochem J 2022;479:1653-708. [PMID: 36043493 DOI: 10.1042/BCJ20220154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Mateus-Silva JR, Oliveira CR, Brandao-Rangel MAR, Silva-Reis A, Olimpio FRDS, Zamarioli LDS, Aimbire F, Vieira RP. A Nutritional Blend Suppresses the Inflammatory Response from Bronchial Epithelial Cells Induced by SARS-CoV-2. J Diet Suppl 2022;:1-15. [PMID: 35930300 DOI: 10.1080/19390211.2022.2103607] [Reference Citation Analysis]
8 Rosa L, Cutone A, Conte MP, Campione E, Bianchi L, Valenti P. An overview on in vitro and in vivo antiviral activity of lactoferrin: its efficacy against SARS-CoV-2 infection. Biometals 2022. [PMID: 35920949 DOI: 10.1007/s10534-022-00427-z] [Reference Citation Analysis]
9 Ward JL, Torres-gonzalez M, Ammons MCB. The Influence of Viral Infections on Iron Homeostasis and the Potential for Lactoferrin as a Therapeutic in the Age of the SARS-CoV-2 Pandemic. Nutrients 2022;14:3090. [DOI: 10.3390/nu14153090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Asmari M, Waqas M, Ibrahim AE, Halim SA, Khan A, Al-harrasi A, Wätzig H, El Deeb S. Microscale Thermophoresis and Molecular Modelling to Explore the Chelating Drug Transportation in the Milk to Infant. Molecules 2022;27:4604. [DOI: 10.3390/molecules27144604] [Reference Citation Analysis]
11 Pang Z, Hu R, Tian L, Lou F, Chen Y, Wang S, He S, Zhu S, An X, Song L, Liu F, Tong Y, Fan H. Overview of Breastfeeding Under COVID-19 Pandemic. Front Immunol 2022;13:896068. [PMID: 35711421 DOI: 10.3389/fimmu.2022.896068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Telek E, Ujfalusi Z, Kemenesi G, Zana B, Jakab F, Hild G, Lukács A, Hild G. A Possible Way to Relate the Effects of SARS-CoV-2-Induced Changes in Transferrin to Severe COVID-19-Associated Diseases. IJMS 2022;23:6189. [DOI: 10.3390/ijms23116189] [Reference Citation Analysis]
13 Bartolomé F, Rosa L, Valenti P, Lopera F, Hernández-Gallego J, Cantero JL, Orive G, Carro E. Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer's Disease Patients. Front Immunol 2022;13:878201. [PMID: 35547737 DOI: 10.3389/fimmu.2022.878201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Iacovelli F, Costanza G, Romeo A, Cosio T, Lanna C, Bagnulo A, Di Maio U, Sbardella A, Gaziano R, Grelli S, Squillaci E, Miani A, Piscitelli P, Bianchi L, Falconi M, Campione E. Interaction of Pelargonium sidoides Compounds with Lactoferrin and SARS-CoV-2: Insights from Molecular Simulations. Int J Environ Res Public Health 2022;19:5254. [PMID: 35564648 DOI: 10.3390/ijerph19095254] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 García-carnero LC, Mora-montes HM. Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis. JoF 2022;8:445. [DOI: 10.3390/jof8050445] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Nakamura M, Tsuda N, Miyata T, Ikenaga M. Antimicrobial effect and mechanism of bovine lactoferrin against the potato common scab pathogen Streptomyces scabiei. PLoS One 2022;17:e0264094. [PMID: 35213576 DOI: 10.1371/journal.pone.0264094] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]